Defunct Company
Total Trials
6
As Lead Sponsor
As Collaborator
0
Total Enrollment
572
NCT00432770
Safety, Pharmacokinetics, and Pharmacodynamics of ARC1779 in Healthy Volunteers
Phase: Phase 1
Role: Lead Sponsor
Start: Dec 31, 2006
Completion: Mar 31, 2007
NCT00507338
Study of ARC1779 in Patients With Acute Myocardial Infarction Undergoing PCI
Phase: Phase 2
Start: Oct 31, 2007
Completion: Feb 29, 2008
NCT00632242
ARC1779 Injection in Patients With Von Willebrand Factor-Related Platelet Function Disorders
Start: Jan 31, 2008
Completion: Dec 31, 2008
NCT00694785
A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of ARC1779 Injection in Patients With Von Willebrand Disease Type 2B
Start: Oct 31, 2008
Completion: Not specified
NCT00726544
Clinical Outcome Study of ARC1779 Injection in Patients With Thrombotic Microangiopathy
Start: Dec 31, 2008
Completion: Mar 31, 2011
NCT00742612
Effect of ARC1779 on Cerebral Microembolism in Patients Undergoing Carotid Endarterectomy
Start: Feb 28, 2009
Completion: Apr 30, 2010